New-onset AF in relation to baseline characteristics
| Variable | New-onset AF, n (%) | HR (95% CIs) | P | |
|---|---|---|---|---|
| Sex | Men | 187 (5.0) | 1.22 (0.99–1.50) | 0.070 |
| Women | 186 (4.1) | |||
| Age, years | ≥ 65 | 306 (6.0) | 3.01 (2.30–3.94) | < 0.0001 |
| < 65 | 67 (2.1) | |||
| Ethnicity | Black | 8 (1.6) | 0.34 (0.17–0.68) | 0.001 |
| Non-Black | 362 (4.7) | |||
| Systolic BP, mmHg | > 173 | 228 (5.5) | 1.62 (1.31–2.00) | < 0.0001 |
| ≤ 173 | 145 (3.5) | |||
| Cornell voltage-duration product | LVH+ | 273 (5.2) | 1.61 (1.26–2.04) | < 0.0001 |
| LVH– | 91 (3.3) | |||
| Coronary heart disease | Present | 106 (5.9) | 1.91 (1.19–3.04) | 0.006 |
| Absent | 22 (3.2) | |||
| Cardiovascular disease | Present | 116 (5.8) | 1.44 (1.15–1.80) | 0.002 |
| Absent | 257 (4.1) | |||
| Serum potassium, mmol/L | < 4.1 | 165 (5.2) | 1.30 (1.05–1.61) | 0.019 |
| ≥ 4.1 | 207 (4.1) | |||
| Urine albumin/creatinine (log) | < 1.25 | 147 (3.7) | 1.44 (1.16–1.78) | 0.001 |
| ≥ 1.25 | 208 (5.3) | |||